中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [6]
地质与地球物理研究所 [5]
大连化学物理研究所 [3]
生态环境研究中心 [1]
合肥物质科学研究院 [1]
近代物理研究所 [1]
更多
采集方式
OAI收割 [16]
iSwitch采集 [1]
内容类型
期刊论文 [17]
发表日期
2024 [1]
2023 [1]
2022 [3]
2021 [2]
2020 [1]
2019 [3]
更多
学科主题
筛选
浏览/检索结果:
共17条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
A Self-Assembled Nano-Molecular Glue (Nano-mGlu) Enables GSH/H
2
O
2
-Triggered Targeted Protein Degradation in Cancer Therapy
期刊论文
OAI收割
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2024, 卷号: 147, 期号: 1, 页码: 372-383
作者:
Sun, Jie
;
Gu, Mingxi
;
Peng, Lvyang
;
Guo, Jing
;
Chen, Peng
  |  
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2025/04/01
Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 10, 页码: 7016-7037
作者:
Li, Daqiang
;
Zhang, Zhuo
;
Li, Yalei
;
Wang, Xinyi
;
Zhong, Hanyue
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2023/10/17
The syn- and post-collision structures related to the Tarim-Qaidam collision: Results of seismic interpretation in the Tarim Basin
期刊论文
OAI收割
ACTA PETROLOGICA SINICA, 2022, 卷号: 38, 期号: 9, 页码: 2634-2664
作者:
Zhou Hui
;
Li YueJun
;
Chen ZhiYong
;
Wen Lei
;
Huang LiLi
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2023/03/31
Late Ordovician-Early Silurian syn-collision structure
Middle Silurian-Middle Devonian post-collision structure
Tarim-Qiadam collision
Tarim Basin
Altun Suture
Proto-Tethys
Collisional orogeny
Accretionary orogeny
Seismic interpretation
Enhanced photoluminescence stability and internal defect evolution of the all-inorganic lead-free CsEuCl3 perovskite nanocrystals
期刊论文
OAI收割
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2022, 卷号: 24
作者:
Gao, Yalei
;
Zhang, Tao
;
Liu, Jun
;
Liu, Hongjun
;
Li, Meixian
  |  
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2022/12/23
Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 236, 页码: 14
作者:
Chen, Jingjing
;
He, Huixin
;
Wei, Aihuan
;
Li, Yalei
;
Cheng, Gang
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/08/16
PROTAC
Pyrrolopyridone
BRD4 S
Selectivity
Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 2, 页码: 488-504
作者:
Liu, Xiaohua
;
Zhang, Yu
;
Li, Yalei
;
Wang, Juan
;
Ding, Huaqian
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2021/05/24
Medulloblastoma
Hedgehog signaling
pathway
Drug resistance
GLI
BRD4
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 209, 页码: 20
作者:
Chen, Jingjing
;
Li, Yalei
;
Zhang, Jie
  |  
收藏
  |  
浏览/下载:73/0
  |  
提交时间:2021/05/24
HDAC
BRD4
Selective dual inhibitors
Anticancer
Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging
期刊论文
OAI收割
JOURNAL OF MATERIALS CHEMISTRY B, 2020, 卷号: 8, 期号: 9, 页码: 1878-1896
作者:
Zhu, Shulei
;
Li, Yalei
;
Huang, Yushu
;
Zhang, Minmin
;
Gu, Xiaofan
  |  
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2020/07/01
EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC
期刊论文
OAI收割
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 页码: 15
作者:
Qin, Jianhua
;
Liu, Yang
;
Yin, Yalei
;
Sun, Mingju
;
Zhan, Xi
  |  
收藏
  |  
浏览/下载:115/0
  |  
提交时间:2019/06/20
Bromodomain
JQ1
MAPK pathway
MYC
EGFR mutation
Sorafenib
Egfr signaling confers resistance to bet inhibition in hepatocellular carcinoma through stabilizing oncogenic myc
期刊论文
iSwitch采集
Journal of experimental & clinical cancer research, 2019, 卷号: 38, 页码: 15
作者:
Yin, Yalei
;
Sun, Mingju
;
Zhan, Xi
;
Wu, Changqing
;
Geng, Pengyu
收藏
  |  
浏览/下载:146/0
  |  
提交时间:2019/05/08
Bromodomain
Jq1
Mapk pathway
Myc
Egfr mutation
Sorafenib